Maren Høland recently received the degree of Master of Science by the University of Oslo, Institute for Molecular Biosciences. In her masters project Maren investigated in situ expression of 11 different protein markers and their prognostic value in malignant peripheral nerve sheath tumors. The main findings were the identification of two different immunohistochemical protein expression profiles that could distinguish a high risk patient group from a low risk group, even among patients in complete remission.
The M.Sc. project was supervised by Dr. Matthias Kolberg and Prof Ragnhild A. Lothe (co-supervisor).
Maren has recently received a PhD grant from the Institute of Clinical Medicine, University of Oslo, and will work in the Lothe group at the Centre for Cancer Biomedicine.
Pharo H, Vedeld HM, Wahlqvist R, Lind GE(2025) Re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30 Eur Urol(in press) DOI 10.1016/j.eururo.2025.07.028, PubMed 40998632
Brodal HP, Pharo H, Vedeld HM, Lind GE(2025) PoDCall: a robust tool for automated droplet classification in DNA-methylation droplet digital PCR Mol Oncol, 19(9), 2472-2473 DOI 10.1002/1878-0261.70105, PubMed 40761129
Gudiño V, Bartolomé-Casado R, Salas A(2025) Single-cell omics in inflammatory bowel disease: recent insights and future clinical applications Gut, 74(8), 1335-1345 DOI 10.1136/gutjnl-2024-334165, PubMed 39904604